Cellular mechanisms of vascular injury mediated by calcineurin inhibitors

Kidney International

Volumn 68, Issue 2, 2005, Pages 898-907

  Lamas, Santiago ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Cyclosporine A; Endothelin 1; Hypertension; Tacrolimus

Indexed keywords

CALCINEURIN INHIBITOR; CALCITRIOL; CALCIUM ANTAGONIST; CALCIUM CARBONATE; CYCLOSPORIN A; ENALAPRIL; ERYTHROPOIETIN; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; PREDNISONE; SUCRALFATE; CALCINEURIN; CYCLOSPORIN; ENDOTHELIN 1; ENZYME INHIBITOR; NITRIC OXIDE; PEROXYNITROUS ACID;

ADULT; BLOOD VESSEL INJURY; CASE REPORT; CHRONIC KIDNEY FAILURE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY AGENESIS; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; PRIORITY JOURNAL; REFLUX NEPHROPATHY; REVIEW; UREMIA; ARTICLE; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DRUG ANTAGONISM; DRUG EFFECT; GRAFT REJECTION; KIDNEY TRANSPLANTATION; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ADULT; CALCINEURIN; CYCLOSPORINE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; NITRIC OXIDE; PEROXYNITROUS ACID;

EID: 26944442068     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00472.x     Document Type: Article

References (64)

1. FLANAGAN WM, CORTHÉSY B, BRAM RJ, CRABTREE GR: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352:803-807, 1991
2. LIU J, FARMER JD, JR., LANE WS, et al: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815, 1991
3. CLIPSTONE NA, CRABTREE GR: Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697, 1992
4. MILLER LW: Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2:807-818, 2002
5. TEXTOR SC, TALER SJ, CANZANELLO VJ, et al: Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl 6:521-530, 2000
6. STEIN CM, HE H, PINCUS T, WOOD AJ: Cyclosporine impairs vasodilation without increased sympathetic activity in humans. Hypertension 26:705-710, 1995
7. MEYER-LEHNERT H, SCHRIER RW: Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction. Hypertension 13:352-360, 1989
8. RODRIGUEZ-PUYOL D, LAMAS S, OLIVERA A, et al: Actions of cyclosporin A on cultured rat mesangial cells. Kidney Int 35:632-637, 1989
9. LINDER L, KIOWSKI W, BUHLER FR, LUSCHER TF: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81:1762-1767, 1990
10. CALVER A, COLLIER J, VALLANCE P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-2554, 1992
11. MORRIS ST, MCMURRAY JJ, RODGER RS, et al: Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 57:1100-1106, 2000
12. OVUWORIE CA, FOX ER, CHOW CM, et al: Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation 72:1385-1388, 2001
13. OflAZ H, TURKMEN A, KAZANCIOGLU R, et al: The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 17:212-216, 2003
14. SUDHIR K, MACGREGOR JS, DEMARCO T, et al: Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation 90:3018-3023, 1994
15. DIEDERICH D, YANG Z, LÜSCHER TF: Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat. J Am Soc Nephrol 2:1291-1297, 1992
16. GALLEGO MJ, LOPEZ FA, RIESCO A, et al: Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: Effect of 1-arginine. Am J Physiol 264 (3 Pt 2):H708-H714, 1993
17. ROULLET JB, XUE H, MCCARRON DA, et al: Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest 93:2244-2250, 1994
18. ORIJI GK, KEISER HR: Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 32:849-855, 1998
19. LOPEZ-ONGIL S, SAURA M, RODRIGUEZ-PUYOL D, et al: Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelial cells. Am J Physiol 271:H1072-H1078, 1996
20. STROES ES, LUSCHER TF, DE GROOT FG, et al: Cyclosporin A increases nitric oxide activity in vivo. Hypertension 29:570-575, 1997
21. CALO L, SEMPLICINI A, DAVIS PA, et al: Cyclosporin-induced endothelial dysfunction and hypertension: Are nitric oxide system abnormality and oxidative stress involved? Transpl Int 13 (Suppl 1):S413-S418, 2000
22. BRACHT C, YAN XW, LAROCCA HP, et al: Cyclosporine A and control of vascular tone in the human forearm: Influence of post-transplant hypertension. J Hypertens 17:357-363, 1999
23. DIEDERICH D, SKOPEC J, DIEDERICH A, DAI FX: Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 23:957-961, 1994
24. LOPEZ-ONGIL S, HERNANDEZ-PERERA O, NAVARRO-ANTOLIN J, et al: Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 124:447-454, 1998
25. GRYGLEWSKI RJ, PALMER RM, MONCADA S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456, 1986
26. GALLE J, LEHMANN-BODEM C, HUBNER U, et al: CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation. Nephrol Dial Transplant 15:339-346, 2000
27. NAVARRO-ANTOLIN J, HERNANDEZ-PERERA O, LOPEZ-ONGIL S, et al: CsA and FK506 up-regulate eNOS expression: Role of reactive oxygen species and AP-1. Kidney Int (Suppl) 68:S20-S24, 1998
28. NAVARRO-ANTOLIN J, REY-CAMPOS J, LAMAS S: Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1. J Biol Chem 275:3075-3080, 2000
29. CALO LA, DAVIS PA, GIACON B, et al: Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: Effect of ramipril. J Cardiovasc Pharmacol 40:625-631, 2002
30. ZOJA C, FURCI L, GHILARDI F, et al: Cyclosporin-induced endothelial cell injury. Lab Invest 55:455-461, 1986
31. TARPEY MM, FRIDOVICH I: Methods of detection of vascular reactive species: Nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 89:224-236, 2001
32. NAVARRO-ANTOLIN J, LOPEZ-MUNOZ MJ, KLATT P, et al: Formation of peroxynitrite in vascular endothelial cells exposed to cyclosporine A. FASEB J 15:1291-1293, 2001
33. NAVARRO-ANTOLIN J, LAMAS S: Nitrosative stress by cyclosporin A in the endothelium: studies with the NO-sensitive probe diaminofluorescein-2/diacetate using flow cytometry. Nephrol Dial Transplant 16 (Suppl) 1:6-9, 2001
34. BECKMAN JS, BECKMAN TW, CHEN J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624, 1990
35. RADI R: Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 101:4003-4008, 2004
36. SHISHEHBOR MH, AVILES RJ, BRENNAN ML, et al: Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289:1675-1680, 2003
37. CASTEGNA A, THONGBOONKERD V, KLEIN JB, et al: Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85:1394-1401, 2003
38. NAVARRO-ANTOLIN J, LOPEZ-MUNOZ MJ, SORIA J, LAMAS S: Superoxide limits cyclosporine-A-induced formation of peroxynitrite in endothelial cells (2). Free Radic Biol Med 32:702-711, 2002
39. MacMillan-CROW LA, CROW JP, KERBY JD, et al: Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 93:11853-11858, 1996
40. MacMillan-CROW LA, THOMPSON JA: Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys 366:82-88, 1999
41. GUO W, ADACHI T, MATSUI R, et al: Quantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin II-infused rat kidney. Am J Physiol (Heart Circ Physiol) 285:H1396-H1403, 2003
42. VETTER M, CHEN ZJ, CHANG GD, et al: Cyclosporin A disrupts bradykinin signaling through superoxide. Hypertension 41:1136-1142, 2003
43. EMESON EE, SHEN ML: Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. Am J Pathol 142:1906-1915, 1993
44. BUNCHMAN TE, BROOKSHIRE CA: Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 88:310-314, 1991
45. TAKEDA Y, MIYAMORI I, YONEDA T, TAKEDA R: Increased concentration of endothelin messenger RNA in the mesenteric arteries of cyclosporine-induced hypertensive rats. Am J Hypertens 6:427-430, 1993
46. DAVIS LS, HALEEN SJ, DOHERTY AM, et al: Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A. J Am Soc Nephrol 4:1448-1454, 1994
47. GONZALEZ-SANTIAGO L, LOPEZ-ONGIL S, LAMAS S, et al: Imbalance in endothelial vasoactive factors as a possible cause of cyclosporin toxicity: A role for endothelin-converting enzyme. J Lab Clin Med 136:395-401, 2000
48. WILASRUSMEE C, DA SILVA M, SIDDIQUI J, et al: Role of endothelin-1 in microvascular dysfunction caused by cyclosporin A. J Am Coll Surg 196:584-591, 2003
49. WILASRUSMEE C, ONDOCIN P, BRUCH D, et al: Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor. Surgery 134:384-389, 2003
50. LONGONI B, BOSCHI E, DEMONTIS GC, et al: Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels. FASEB J 15:731-740, 2001
51. NGUYEN NS, COTTET-MAIRE F, BUETLER TM, et al: Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells. Free Radic Biol Med 27:1267-1275, 1999
52. SERINO F, GREVEL J, NAPOLI KL, et al: Oxygen radical formation by the cytochrome P450 system as a cellular mechanism for cyclosporine toxicity. Transplant Proc 26:2916-2917, 1994
53. ALVAREZ-ARROYO MV, YAGUE S, WENGER RM, et al: Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: Role of vascular endothelial growth factor. Circ Res 91:202-209, 2002
54. CARAMELO C, ALVAREZ-ARROYO MV, YAGUE S, et al: Cyclosporin A toxicity, and more: Vascular endothelial growth factor (VEGF) steps forward. Nephrol Dial Transplant 19:285-288, 2004
55. ALVAREZ ARROYO MV, SUZUKI Y, YAGUE S, et al: Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity. Transplantation 74:1618-1624, 2002
56. HERNANDEZ GL, VOLPERT OV, INIGUEZ MA, et al: Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 193:607-620, 2001
57. LAU DC, WONG KL, HWANG WS: Cyclosporine toxicity on cultured rat microvascular endothelial cells. Kidney Int 35:604-613, 1989
58. LIGTENBERG G, HENE RJ, BLANKESTIJN PJ, KOOMANS HA: Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus. J Am Soc Nephrol 12:368-373, 2001
59. JEANMART H, MALO O, CARRIER M, et al: Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function. J Heart Lung Transplant 21:990-998, 2002
60. FELLSTROM B: Cyclosporine nephrotoxicity. Transplant Proc 36:220S-223S, 2004
61. RAYMOND MS, MOLLICA L, VIGNEAULT N, et al: Blockade of the apoptotic machinery by cyclosporine A redirects cell death toward necrosis in arterial endothelial cells: regulation by reactive oxygen species and cathepsin D. FASEB J 17:515-517, 2003
62. MAXWELL MM, PASINELLI P, KAZANTSEV AG, BROWN RH JR.: RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci USA 101:3178-3183, 2004
63. NISHIYAMA A, KOBORI J, FUKUI T, et al: Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 42:754-760, 2003
64. LASSILA M: Interaction of cyclosporine A and the renin-angiotensin system; new perspectives. Curr Drug Metab 3:61-71, 2002